Engaged in pharmaceutical formulations and healthcare products. Manufactures tablets, syrups, and related dosage forms. Revenue arises from branded and contract manufacturing. Focuses on regulatory-compliant production. Serves domestic pharma distributors. Operates formulation-based business.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.
24 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.